JANX logo
JANX NASDAQ US

Janux Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jun 2021
$14.84
▲ +$0.33 (+2.27%)
Vol 1.3M
3
Quality Score
fail
Mkt Cap
$830.0M
ROE
-10.2%
Margin
-243.1%
D/E
0.00
Beta
2.85
52W
$14–$62

Wall Street Consensus

26 analysts · Apr 2026
9
Strong Buy
14
Buy
3
Hold
0
Sell
0
Strong Sell
88.5%
Buy Rating

Price Chart

Similar Stocks

AKTS
Aktis Oncology Inc
CDNA
CareDx Inc
P/E 15.9
$969.0M
INBX
Inhibrx Biosciences Inc
$1.1B
MPLT
MapLight Therapeutics Inc
$797.0M
ORIC
Oric Pharmaceuticals Inc
$796.6M
XNCR
Xencor Inc
$1.1B
ABUS
Arbutus Biopharma Corp
$925.1M
CGEM
Cullinan Therapeutics Inc
$611.4M

Earnings

Beat rate: 75.0%
Next Report May 06, 2026
EPS Estimate: $-0.57
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.57 — —
Dec 2025 $-0.66 $-0.51 +$0.15
Sep 2025 $-0.63 $-0.39 +$0.24
Jun 2025 $-0.48 $-0.55 $-0.07

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -11.5% -11.5% -11.5% -11.5% -10.2% -10.2%
P/E (TTM) — — — — — —
Net Margin — -463.9% -463.9% -463.9% -243.1% -243.1%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 47.03 47.03 47.03 47.03 35.86 35.86

Key Ratios

ROA (TTM)
-9.8%
P/S (TTM)
83.00
P/B
3.0
EPS (TTM)
$-1.68
CF/Share
$-1.42
Rev Growth 3Y
+42.8%
52W High
$61.59
52W Low
$13.76
$13.76 52-Week Range $61.59

How does JANX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

JANX AAPG ABEO ABOS ABP

JANX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
83.0
▲ 546% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
3.0
▲ 23% above peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

JANX profitability vs Biotechnology peers

ROE
-10.2%
▲ 85% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-243.1%
▲ 15% above peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-9.8%
▲ 79% above peers (-46.7%)
vs Peers
vs Industry
Top tier

JANX financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
35.9
▲ 708% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.9
▲ 194% above peers (1.0)
vs Peers
vs Industry
More volatile

JANX fundamentals radar

JANX Peer median Industry

JANX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

JANX vs peers: key metrics

Latest News

No related news yet